STARANZANO, Italy—Safilens S.r.l. has received approval from the U.S. Patent Office for contact lenses which release hyaluronic acid, a new technology that the company said helps maintain comfort in the eye’s tear film. The company said its U.S. patent approval follows by similar approvals in Europe six months ago.
“To remain competitive in the market there are only two keywords: research and innovation,”said Fernando Garbellotto, president of Safilens. Investments we pursue will also allow us to penetrate the U.S. market with the Safe Gel technology, a true innovation in the field of contact lenses and patient comfort. “
Read the Full Story at Vision Monday